Here’s a summary of the Liver Disease News column “What to expect from a liver transplant evaluation (by Kathryn Hudson, February 19, 2026).

LiverRight providers manage adult liver disease patients longitudinally via telemedicine, and in some cases a Liver Transplant becomes a possible and essential clinical intervention.

🧠 Superb Personal Perspective on Evaluation

  • The author, living with metabolic dysfunction-associated steatohepatitis (MASH) and cirrhosis, describes her recent liver transplant evaluation and what to expect from the process.

🗓️ The Evaluation Experience

  • Evaluation is comprehensive and time-intensive, involving hours of meetings and tests.
  • You’ll see many members of the transplant team — including nurse coordinators, surgeons, social workers, physicians, and specialists — each with a distinct role in assessing your readiness.

👥 Meeting the Team

  • Nurse coordinator: outlines the day, explains roles, and sets expectations.
  • Surgeon: answers questions about surgery and readiness.
  • Social worker: evaluates social support and resources, which are essential for recovery.
  • Program leadership/physicians: review your history, symptoms, and surgical considerations.

🧪 Tests and Assessment

  • Evaluations include extensive blood draws and health assessments to understand your liver disease and general health.

📞 Follow-Up

  • Results come quickly; in the author’s case, she learned soon after that she would remain listed on the transplant list after confirming she was stable.

💭 Key Takeaways

  • The evaluation can be daunting, thorough, and emotionally challenging, but it’s a critical step in preparing for transplant surgery.
  • A strong healthcare team and personal support make the process more manageable.

🏥 Purpose of the Evaluation

A liver transplant evaluation determines:

  1. Medical necessity – Is transplant indicated based on disease severity and prognosis?
  2. Safety – Is the patient medically fit to undergo major surgery?
  3. Benefit – Will transplant meaningfully improve survival and quality of life?
  4. Readiness – Does the patient have adequate psychosocial and logistical support?

🧪 1. Medical Evaluation

A. Liver Disease Severity

  • MELD-Na score (based on bilirubin, INR, creatinine, sodium)
  • Assessment of:
    • Decompensation (ascites, variceal bleeding, encephalopathy)
    • Hepatocellular carcinoma (HCC) staging
    • Portal hypertension complications

B. Comprehensive Lab Testing

  • CMP, CBC, coagulation panel
  • Viral hepatitis panel (HBV, HCV)
  • HIV screening
  • Autoimmune markers
  • Iron studies, ceruloplasmin (if indicated)
  • Tumor markers (AFP for HCC)
  • Blood type (for listing)

C. Cardiovascular Assessment

Major surgery requires cardiac clearance:

  • EKG
  • Echocardiogram
  • Stress test (nuclear or dobutamine)
  • Cardiology consult if risk factors present

D. Pulmonary Evaluation

  • Chest X-ray
  • Pulmonary function tests
  • Screening for hepatopulmonary syndrome or portopulmonary hypertension

E. Imaging

  • Abdominal CT or MRI (triple-phase imaging)
  • Doppler ultrasound (portal/hepatic vasculature)
  • Cancer screening for HCC

F. Infection & Immunization Review

  • TB screening
  • Vaccination status (HAV, HBV, pneumococcal, influenza, etc.)
  • Dental evaluation (to eliminate infection sources)

🧠 2. Psychosocial Evaluation

Conducted by social workers and/or transplant psychologists:

  • Assessment of:
    • Mental health stability
    • Substance use history (alcohol, drugs)
    • Adherence history
    • Insight into disease
  • Confirmation of:
    • Reliable caregiver/support person
    • Transportation plan
    • Housing stability
  • Financial counseling:
    • Insurance coverage
    • Medication affordability (immunosuppression is lifelong)

⚖️ 3. Contraindications Screening

Absolute contraindications may include:

  • Active uncontrolled infection
  • Active malignancy (outside transplant criteria)
  • Severe irreversible cardiopulmonary disease
  • Ongoing substance misuse
  • Inability to adhere to care plan

Relative contraindications:

  • Advanced age (case-by-case)
  • Morbid obesity
  • Frailty
  • Limited social support

📋 4. Multidisciplinary Review Committee

After testing is complete:

  • Surgeons
  • Hepatologists
  • Coordinators
  • Social workers
  • Pharmacists
  • Psychologists
  • Financial coordinators

The team decides whether to:

  • ✅ List for transplant
  • ⏳ Defer (optimize medical condition first)
  • ❌ Decline listing (with explanation and possible second-opinion option)

🏷️ If Approved: UNOS Listing

Once listed:

  • Patient receives a MELD score.
  • Organ allocation is based primarily on medical urgency (MELD-Na), with exceptions (e.g., HCC).
  • Ongoing labs are required to maintain active status.

⏳ Timeline

  • Evaluation: 1–4 weeks (sometimes compressed into 1–2 intensive days)
  • Listing decision: days to weeks after completion
  • Wait time: highly variable (region + MELD dependent)

📌 Key to the LiverRight Approach

  • The evaluation is rigorous by design.
  • It’s not just about liver labs — it’s about whole-person readiness.
  • Social support is as critical as medical severity.
  • Many patients require optimization before being listed.